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Abstract: The field of percutaneous intervention for chronic total occlusion (CTO) has enjoyed sig-
nificant innovations in the recent years. Novel techniques and technologies have revolutionized the 
field and have resulted in considerably higher success rates even in patients with high anatomical 
complexity. Successful CTO recanalization is associated with significant clinical benefits, such as the 
improvement of angina and quality of life, reduced rates of surgical revascularization, improvement of 
left ventricular function and decreased mortality rates. However, complex CTO procedures often re-
quire prolonged x-ray exposure which have been associated with adverse long term outcomes. 
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INTRODUCTION 
 Radiation exposure is higher during percutaneous coro-
nary interventions (PCI) for chronic total occlusions (CTO) 
compared to non-CTO interventions because of prolonged 
fluoroscopic time and repeated cine angiography [1]. Al-
though radiation skin injury is rare, the risks of radiation-
related complications are greater in CTO procedures. 
Moreover, operator and lab staff exposure can result in 
longterm adverse outcomes, such as cataracts and malignan-
cies, therefore reducing radiation exposure is a key factor in 
CTO interventions. 
RADIATION DOSES IN CTO PROCEDURES 
 There are three different values that are currently meas-
ured by modern interventional fluoroscopic equipment: (a) 
the entrance surface air kerma (ESAK), measured in Gray 
(Gy), which represents the radiation energy released at the 
point where the X-ray beam enters the patient’s skin surface 
and includes both the incident air kerma and radiation back-
scattered from the tissue, (b) the dose area product (DAP), 
measured in Gy.cm2, which represents the product of the 
dose in air within the X-ray beam and the beam area, and is 
therefore a measure of all the radiation that enters the patient 
and (c) the fluoroscopic time (FT), measured in minutes, 
which is the time during a procedure that fluoroscopy is 
used. The ESAK is used to measure the deterministic risk to 
the patient such as skin injury, while the DAP is used to 
measure the stochastic risk of the patient, which involves the 
likelihood of developing malignancies or genetic defects in 
the future. FT does not include cine acquisition imaging and 
is therefore inadequate to assess patient radiation. 
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 A plain chest radiography produces a DAP of 0.08 
Gy.cm2 with a background equivalent of three days, while 
the equivalents for a non-CTO PCI with one stent are 36 
Gy.cm2 and 3.7 years [2]. According to a study by Suzuki et 
al. [1] the median ESAK for a CTO PCI was 4.6 Gy, com-
pared to 2.4 Gy, 1.5 Gy and 1.2 Gy for multivessel, single-
vessel multiple stenosis and single stenosis PCI respectively.  
 Several lesion- and patient-related risk factors have been 
shown to affect radiation dose during percutaneous interven-
tions. In a study of 1933 PCI procedures Fetterly et al. [3] 
found that lesion complexity, PCI of left circumflex artery, 
previous coronary artery bypass grafting (CABG), body 
mass index (BMI) and the number of treated lesions corre-
lated to an increased ESAK. Similar results were found in a 
larger study by Delewi et al. [4] which included 9850 PCI 
procedures. They demonstrated that high BMI, previous his-
tory of coronary artery bypass grafting, the number of treated 
lesions and CTO interventions were associated with the 
highest patient radiation exposure. 
DETERMINISTIC EFFECTS 
 Radiation-induced skin injury is an infrequent compli-
cation during PCI, but appears more often in CTO interven-
tions as a result of prolonged fluoroscopy times. Radiation 
toxicity is rare with <5 Gy but patients with higher doses 
should be followed up 2-3 weeks after the procedure and 
assessed for development of new skin changes. At Grade I 
radiation-induced skin injury a faint erythema can be seen 
during the first 48 hours after exposure. Following a latent 
phase that can last up to 5 weeks, moderate to brisk 
erythema with oedema can be observed. Larger doses of 
radiation can result in Grade IV injury with skin necrosis or 
ulceration within 2 weeks after exposure (Fig. 1), (Table 1) 
[5].  
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Fig. (1). Radiation-induced skin injury. 
 Radiation-induced skin injury appears to be the least fre-
quently reported complication following CTO intervention. 
In a meta-analysis of 65 studies Patel et al. [6] showed an 
incidence of <0.01% with only 3 reported cases among 2,857 
patients. However, radiation skin injury was the least fre-
quently reported CTO complication, with only 11% of the 
studies reporting on its occurrence. In another metanalysis of 
retrograde CTO interventions, El Sabbagh et al. [7] reported 
an incidence of 0.5%, although only 2 out of the 26 studies 
(0.08%) reported this complication. Morino et al. [8] pub-
lished the outcomes for 498 patients and 528 CTO lesions 
included in the J-CTO registry (Multicenter CTO Registry of 
Japan) and no incidents of radiation-induce skin injuries were 
reported. The incidence of radiation skin in the most recent 
CTO registries and meta-analyses is summarised in Table 2. 
STOCHASTIC EFFECTS 
 Radiation dose exposure has been related to an additional 
risk of developing solid tumours [9]. The Biological Effects 
of Ionizing Radiation (BEIR) VIII risk model suggests that 
the risk of malignancy increases proportionally to the dose of 
the radiation, with no low-dose threshold [10]. At low doses 
of exposure, the risk of developing a malignancy is naturally 
low, but not zero. Minimal data on the risk of malignancy 
related to radiation exposure during PCI are available. God-
ino et al. [11] estimated the malignancy risk due to radiation 
Table 1. Staging of radiation skin injury [31]. 
Grade Skin appearance Radiation dose Time after radiation exposure 
1 Faint erythema or desquamation > 2 Gy First 48 hours 
2 Moderate to brisk erythema or moist desquamation. Moderate swelling. > 15 Gy 2-5 weeks 
3 
Confluent, moist desquamation > 1.5 cm diameter, which is not confined to the 
skin folds. Pitting oedema 
> 40 Gy 6-7 weeks 
4 Skin necrosis or ulceration of full thickness dermis > 550 Gy 2 weeks 
   
Table 2. Radiation doses in recent CTO registries and meta-analyses. 
  Study type Characteristics Year CTO lesions (n) Radiation skin injury (%) Fluoroscopy time 
Lin et al. [32] Retrospective study   2014 516 NR 43 ± 27 
# 
42 ± 24 ## 
El Sabbagh et al. [7]  Metanalysis Retrograde only 2014 3493 0.5% 82 ± 34 
Christopoulos et al. [33] Registry   2014 496 NR 41 (26-65) * 
Michael et al. [34] Registry   2013 1361 NR 42 ± 29 
Karmpaliotis et al. [35] Registry Retrograde only 2012 462 NR 61 ± 40 
Tsuchikane et al. [36] Registry Retrograde only 2013 801 NR 95 ± 52 
Patel et al. [37] Metanalysis   2013 18941 <0.01 NR 
Galassi et al. [38] Registry   2011 1983 NR 42 ± 47 
Morino et al. [8] Registry   2010 528 0 45 (1-301) * 
Aguiar-Souto et al. [39] Retrospective study   2010 227 NR 32 (19-47) * 
#CI-AKI group, ## non CI-AKI group, CI-AKI: contrast induced acute kidney injury, * Median (range) 
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exposure in patients undergoing PCI for acute ST-elevation 
myocardial infarction (STEMI) and patients undergoing 
CTO PCI by incorporating the effective radiation dose into 
the Biological Effects of Ionizing Radiation (BEIR) VII 
model [12]. They found that the number of estimated addi-
tional lung and bone marrow malignancy cases were on av-
erage two times higher in patients treated for CTOs com-
pared to STEMI patients. Nevertheless, the above observa-
tions have not yet been confirmed in epidemiological studies 
and there is therefore insufficient evidence to defer a CTO 
intervention based on concerns over radiation exposure [13]. 
RADIATION EXPOSURE EFFECTS TO OPERATORS 
 Chronic exposure to low doses of ionising radiation has 
shown to cause DNA damage in interventional cardiologists, 
which appears to correlate with the number of years of cathe-
terization laboratory experience [14]. Venneri et al. [15] used 
the BEIR VII model to show that interventionalists had an 
increased cancer risk caused by professional radiation expo-
sure. Recently published case clusters of interventional car-
diologists with left sided brain neoplasms have raised the 
existing concerns, since radiation exposure to the left side is 
higher during PCI [16-18]. Despite the above, the risks re-
lated to radiation exposure in operators remains uncertain 
and further studies are required.   Radiation-induced cataracts represents another occupa-
tional hazard to interventional cardiologists. The RELID 
(Retrospective evaluation study of lens injuries and dose) 
study showed that they have a three-fold higher rate of poste-
rior subcapsular lens opacities compared to unexposed indi-
viduals. Although the risk of developing cataracts is dose-
dependent [19], it appears to be lower for regular users of 
protective lead glasses [20]. The International Commission 
on Radiological Protection (ICRP) have suggested a thresh-
old dose to the lens of 20 mSv per year, averaged over 5 
consecutive years, with a maximum of 50 mSv in a single 
year [21]. 
METHODS FOR REDUCING RADIATION DURING 
CTO INTERVENTIONS 
A). Pre-procedural Strategies 
 Careful selection of patients and early assessment of the 
risk factors that are associated with high risk for radiation 
injury is of primary importance. Patients with recent radia-
tion exposure are at particularly high risk of radiation skin 
injury [22]. Every patient should be consented on the risks of 
radiation-related complications and careful examination of 
the skin should be performed prior to starting a CTO proce-
dure. Moreover, the ‘CTO team’, including physicians, 
nurses and technicians, should always review the angi-
ographic images prior to the procedure in order to under-
stand the anatomy and plan the interventional strategy. Spe-
cific radiographic views that are most likely to be useful 
should be identified early in order to avoid unnecessary ra-
diation exposure.  
 Computed tomography coronary angiography (CTCA) is 
a useful tool for CTO pre-procedural planning. Although the 
contribution of multislice CT (MSCT) is approximately 19 
mSv [23] the total radiation dose can be decreased signifi-
cantly with successful CTO road mapping, based on the ad-
ditional information on lesion characteristics. Incorporation 
of ECG-pulsed modulation of the tube current [24] and the 
use of new generation MSCT equipment can lower the effec-
tive radiation dose significantly [2]. 
 Finally, each cardiac lab should have an established ra-
diation safety program and operators should undergo com-
pulsory training on radiation dose management and safety. 
Studies have shown that radiation doses can be reduced up to 
34% if operators have recently attended an informative con-
ference on appropriate use of radiation and changes in x-ray 
delivery settings [25].  
B). Intra-procedural Strategies 
 Staff radiation dose should be closely monitored with 
personal dose monitors and dosimeter records should be pro-
vided to operators regularly. The ICRP recommends the use 
of two dosimeters [21]: one under the protective garment, 
usually at waist height, and a second outside the thyroid col-
lar. If unusually high doses are recorded a review of staff 
practice patterns and adoption of further safety measures 
should be applied.  
 Protective 0.5 mm lead aprons, thyroid shielding, shin leg 
covers and radiation-specific glasses can stop up to 95% of 
the scattered radiation and should be worn by all CTO opera-
tors [22]. Apart from the commonly used radiation shielding, 
additional protection could be achieved during CTO inter-
ventions with below table mounted shielding and the re-
cently developed Trinity Radiation Protection system [26]. 
The latter consists of a combination of fixed shields, radia-
tion drapes and interconnecting flexible radiation resistant 
materials that create a complete radiation protection envi-
ronment for the operators. 
 All CTO operators should be familiar with and apply the 
ALARA (As Low As Reasonably Achievable) principle, 
which means using all relevant methods and strategies in 
order to minimize radiation dose. Radiation exposure should 
be closely monitored at any time during the procedure. The 
operator should be alerted by the cardiac lab team when ra-
diation levels exceed certain limits in order to balance the 
risks and benefits of discontinuing the procedure. A dose of 
10 Gy ESAK has been suggested as a threshold at which a 
CTO operator should discontinue the procedure provided it 
is safe to do so, unless lesion crossing has occurred and the 
procedure is expected to be completed within a short period 
of time [27]. 
 Increasing the distance between the patient and the X-ray 
tube by positioning the table at a higher level can result in 
significant reduction of radiation dose, although this should 
never affect the operator’s comfort [28]. Higher magnifica-
tion increases the patient’s dose and should only be utilized 
in special circumstances. Moreover, all CTO operators 
should be familial with undergoing procedures at lower 
framing rates per second (fps) (6.0-7.5 fps instead of 15 fps) 
and using pulsed fluoroscopy mode rather than the digital 
cine mode storage. The number of acquisition runs should be 
held for optimising the strategy and assessing possible com-
plications. Altering the beam angulation during the proce-
dure by rotating the x-ray tube more than 40° can reduce the 
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patient's skin dose and minimize irradiation of a particular 
portion of the patient’s skin [29, 30]. Steep angles have been 
linked to higher radiation doses due to penetration through 
more layers of tissue and should therefore be avoided [28]. 
Collimation decreases scatter radiation and the overall dose 
received by the patient. The use of additional copper filters 
reduces primary beam exposure and can enhance focused 
visualization. 
CTO SPECIFIC TECHNIQUES 
 Adoption of the hybrid approach with early switch from a 
failing strategy maximizes the chance of procedural success, 
reduces procedure time and minimises radiation [27]. Al-
though there are no specific time limits for each of the algo-
rithm steps, operators should stop pursuing a technique that 
has not resulted in any significant progress during a reason-
able period of time [27].  
 The use of certain techniques during CTO interventions 
can result in significant reduction of total radiation exposure: 
• The trapping technique for equipment exchange (bal-
loon inflation inside the guiding catheter to fix the 
wire). 
• During dual injections, the donor vessel is injected first 
to allow time to fill the distal vessel. Fluoroscopy or 
cine acquisition begins 1-2 seconds later and it is fol-
lowed by injection of the occluded vessel. 
• The use of intravascular ultrasound (IVUS) for proxi-
mal cap identification, re-entry guidance, assessment 
of retrograde wire position in reverse CART and stent 
optimisation. 
• Marking the length of the wire that can be advanced 
safely without exiting the microcatheter during wire 
exchanges or when modifying the wire’s tip bend. A 
pre-attached torquer at the end of the inserted wire or a 
stable marker on the table can be used. 
 The methods for reducing radiation during CTO interven-
tions are summarised in Table 3. 
C). Post-procedural Strategies and Follow Up 
 Post-procedure dose analysis is important in order to de-
termine further management and follow up, especially if a 
repeat procedure is planned and the initial procedure resulted 
in high radiation exposure. The CTO procedure report 
should include all available radiation dose parameters, such 
as the fluoroscopy time, ESAK and DAP. 
 Post-procedure follow up should be guided by the Air 
Kerma Dose that the patient received during the CTO inter-
vention [22]: 
• 5 Gy: patients should be educated regarding potential 
skin changes on their back. A thorough examination of 
the skin should be performed 1 month following the 
procedure and if there is evidence of radiation-induced 
skin injury an appropriate specialist referral should be 
considered. 
• 10 Gy: patients should be educated accordingly and 
followed up after 2-4 weeks. A qualified physicist 
should promptly be asked to calculate peak skin dose. 
• 15 Gy: dosed above this level are identified by the 
Joint Commission as a sentinel event, therefore hospi-
tal risk management and regulatory authorities need to 
be contacted within 24 hours after the procedure. No 
interventional procedure should reach this level unless 
there is a life threatening complication that necessi-
tates obligatory percutaneous fluoroscopic reversal. 
CONCLUSIONS 
 The field of CTO-PCI has evolved significantly in recent 
years and the hybrid approach to CTO offers the opportunity 
to treat more complex anatomy successfully and meet the 
needs of a wider patient population. Prevention of complica-
tions related to use of radiation represents a major compo-
Table 3. Methods for reducing radiation during CTO interventions. 
Pre-procedure Intra-procedure Post-procedure 
Patient selection and risk assessment Dosimeters Dose documentation 
Consent Protection clothing Follow up 
Review films Shielding   
CTCA ALARA principle   
Radiation safety program Alert operator when radiation exceeds limits   
Compulsory training on radiation safety and management Table position at higher level   
  Lower magnification   
  Lower frame rates   
  Changing beam angulation   
  Collimation   
  Procedure techniques   
CTO: chronic total occlusion, CTCA: computed tomography coronary angiography, ALARA: As Low As Reasonably Achievable 
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nent of a successful CTO intervention. Operator awareness 
and use of all the required precautions improves patient, staff 
and physician safety. 
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